Bajaj Consumer Care Limited has informed the Exchange about Transcript
BAJAJCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
New MD Naveen Pandey (first earnings call) reported stand-alone sales of INR 244.5 crores (+3.2% YoY) and consolidated sales of INR 259.5 crores (+7.4% YoY), with stand-alone EBITDA up 11.6% to INR 42.8 crores at a 17.5% margin (improvement of 130 bps YoY and 340 bps sequentially). Gross margin expanded 140 bps YoY to 56.6% on better mix and selective price hikes in the oil portfolio. Stand-alone PAT was INR 39 crores (16% margin). Vishal Personal Care (Banjara's) is now a 100% subsidiary after the balance 51% acquisition completed in Q1, contributing INR 15.5 crores revenue at low-teens EBITDA margin. International business declined 20% YoY due to tariff issues and distributor transitions in GCC. Management is focused on reviving ADHO growth, expanding distribution via Project Aarohan (25,000+ new outlets added), and gradually integrating Banjara's distribution over 4-6 quarters. Raw material pressures flagged: 25% inflation in RMO and near-doubling of copra prices.
Margin trajectory is the key positive signal — management explicitly guided improvement from current 17-18% EBITDA margin toward industry average (low-mid 20s), which if achieved would be a meaningful re-rating catalyst. However, near-term growth remains modest (mid-single digits ex-acquisition) and international headwinds plus input cost inflation pose risks. New MD's cautious tone and repeated refusal to give forward guidance may temper near-term expectations.